False‐positive reverse transcriptase polymerase chain reaction screening for SARS‐CoV‐2 in the setting of urgent head and neck surgery and otolaryngologic emergencies during the pandemic: Clinical implications
Male
RT‐PCR
Pneumonia, Viral
610
head and neck surgery
Betacoronavirus
03 medical and health sciences
0302 clinical medicine
COVID‐19
Nasopharynx
616
Preoperative Care
Humans
False Positive Reactions
Lung
Pandemics
preoperative testing
Aged, 80 and over
Reverse Transcriptase Polymerase Chain Reaction
SARS-CoV-2
pandemic
COVID-19
Middle Aged
COVIDâ€19
Otorhinolaryngologic Surgical Procedures
3. Good health
Otorhinolaryngology
Florida
RNA, Viral
Female
Emergencies
Coronavirus Infections
RTâ€PCR
DOI:
10.1002/hed.26317
Publication Date:
2020-06-12T12:06:57Z
AUTHORS (11)
ABSTRACT
AbstractBackgroundNo reports describe falsepositive reverse transcriptase polymerase chain reaction (RT‐PCR) for novel coronavirus in preoperative screening.MethodsPreoperative patients had one or two nasopharyngeal swabs, depending on low or high risk of viral transmission. Positive tests were repeated.ResultsForty‐three of 52 patients required two or more preoperative tests. Four (9.3%) had discrepant results (positive/negative). One of these left the coronavirus disease (COVID) unit against medical advice despite an orbital abscess, with unknown true disease status. The remaining 3 of 42 (7.1%) had negative repeat RT‐PCR. Although ultimately considered falsepositives, one was sent to a COVID unit postoperatively and two had urgent surgery delayed. Assuming negative repeat RT‐PCR, clear chest imaging, and lack of subsequent symptoms represent the “gold standard,” RT‐PCR specificity was 0.97.ConclusionsIf false positives are suspected, we recommend computed tomography (CT) of the chest and repeat RT‐PCR. Validated serum immunoglobulin testing may ultimately prove useful.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (31)
CITATIONS (40)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....